Atlas Trials

Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

Clinical trial NCT03725033 · COMPLETED

Trial details

NCT number
NCT03725033
Sponsor
Materia Medica Holding
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Impaired Glucose Tolerance
Start date
2018-10-10
Primary completion
2020-03-23
Enrollment
538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.